Geneos Wealth Management’s Barings Corporate Investors MCI Stock Holding History

Geneos Wealth Management’s Portfolio MCI Stock Details MCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-294	Closed	-$6.89K	–	3189
2025 Q1	$6.89K	Sell	294 -3,710	-93%	-$78.1K	﹤0.01%	2675
2024 Q4	$81.6K	Sell	4,004 -121	-3%	-$2.39K	﹤0.01%	1137
2024 Q3	$82.2K	Buy	+4,125	New	+$76.4K	﹤0.01%	1026
2018 Q1	–	Sell	-320	Closed	-$4K	–	2212
2017 Q4	$4K	Hold	320	–	–	﹤0.01%	1878
2017 Q3	$5K	Hold	320	–	–	﹤0.01%	1756
2017 Q2	$4K	Hold	320	–	–	﹤0.01%	1792
2017 Q1	$4K	Hold	320	–	–	﹤0.01%	1745
2016 Q4	$4K	Hold	320	–	–	﹤0.01%	1692
2016 Q3	$5K	Buy	+320	New	+$5.85K	﹤0.01%	1574

Other funds holding MCI

BIA

BHK Investment Advisors Birmingham, Alabama $299M AUM 13.28% 1-Year Est. Return

CFMC

Curbstone Financial Management Corp Manchester, New Hampshire $587M AUM 24.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GWSA

Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Smith Asset Management Chiefland, Florida $127M AUM 5.85% 1-Year Est. Return

SAM

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

SIG

Sky Investment Group Hartford, Connecticut $637M AUM 20.14% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Geneos Wealth Management's MCI Position: Q2 2025 in Review

Geneos Wealth Management sold out of Barings Corporate Investors (MCI) in Q2 2025, closing a stake of 294 shares — an estimated $6.89K sold.

Geneos Wealth Management first reported a position in MCI in Q3 2016 and held it in 9 quarters. The position peaked at $82.2K in Q3 2024. 65 funds tracked by Wall St. Rank hold MCI as of Q2 2025.

Geneos Wealth Management reported no remaining Barings Corporate Investors position as of Q2 2025 after selling out during the quarter.
Geneos Wealth Management sold 294 Barings Corporate Investors shares in Q2 2025, an estimated $6.89K.
Geneos Wealth Management first reported a position in Barings Corporate Investors in Q3 2016 and held it in 9 quarters.
Geneos Wealth Management's Barings Corporate Investors position peaked at $82.2K in Q3 2024.
65 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q2 2025.

Based on Geneos Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.